중동 및 아프리카 약동학 서비스 시장 전망 2031년 - 지역 분석 - 약물 유형(소분자, 대분자 및 백신), 서비스 유형(임상 전 ADME 및 인체 연구, PK/PD 분석 및 보고, 투여 시뮬레이션, 위험 분석 및 기타), 치료적 응용(종양학, 감염성 질환, 신경계 질환, 자가면역 질환, 부인과 질환, 심혈관 질환, 호흡기 질환 및 기타), 최종 사용자(제약 및 생명공학 회사, 계약 연구 기관 및 기타)
만성 및 감염성 질환의 유병률 증가로 중동 및 아프리카 약동학 서비스 시장이 강화됩니다
당뇨병, 암, 자가면역 질환과 같은 만성 질환의 유병률 증가는 전 세계적으로 약물 개발 노력의 주요 원동력이 되었습니다. 세계보건기구(WHO)의 2024년 데이터에 따르면 전 세계적으로 약 4억 2,200만 명이 당뇨병을 앓고 있으며, 이러한 사례는 대부분 중저소득 국가에서 발견되어 매년 약 150만 명이 사망합니다. 제약 회사는 다양한 질병을 치료하는 약물 개발의 최전선에 있습니다. 약동학 연구는 인체 내에서 흡수, 분포, 대사, 제거(ADME) 과정을 분석하여 이러한 약물이 환자의 신체에서 어떻게 작용하는지 이해하는 데 필수적입니다. 약물이 전신 순환계로 흡수되면 약물이 작용 부위(예: 혈장)에 도달하는 속도와 농도에 영향을 미칩니다. 신체 전체의 약물 분포 패턴은 생화학적 특성과 신체 생리학에 따라 다릅니다. 대사는 신체에서 약물을 후속 화합물로 처리하는 것을 포함합니다. 이 단계는 약물을 수용성 물질로 전환하여 신장 청소에 적합하게 만드는 데 도움이 됩니다. 대사는 또한 코데인과 같은 전구약을 활성 대사 산물로 전환하는 데 중요합니다. 신체에서 약물을 배출하는 것은 주로 신장에 의해 조절되지만, 여러 경우에 약물은 폐, 피부 또는 위장관을 통해 배출될 수 있습니다. ADME 역학은 신체 내 약물의 생물학적 이용률을 정의하고, 약물의 유지 용량은 클리어런스 시간(원하는 혈장 농도를 생물학적 이용률로 나눈 값)을 기준으로 계산됩니다. 클리어런스를 이해하면 의사가 적절한 투여 속도를 계산할 수 있습니다.
약동학 연구는 약물의 효능과 안전성을 이해하기 위해 연구 대상자의 약물 투여 요법을 최적화하는 데 중점을 둡니다. 이러한 연구는 장기 치료를 위해 개발된 약물의 안전성을 보장하는 데 필수적이며, 만성 질환 관리에서 약물 제형의 적합성과 안정성을 평가하는 데 도움이 됩니다. 따라서 만성 및 감염성 질환의 부담이 증가함에 따라 안전하고 효과적인 개인화된 치료법을 개발하기 위한 약동학 연구의 중요성이 강조됩니다.
중동 및 아프리카 약동학 서비스 시장 개요
남아프리카는 중동 및 아프리카의 약동학 서비스 시장에서 가장 큰 점유율을 차지합니다. 남아프리카 공화국 정부는 투자 인센티브를 제공하고, 지적 재산권(IP) 권리를 보호하기 위한 조치를 취하고, 세무 규칙을 간소화하고, 더 나은 규제 정책을 부과하여 궁극적으로 국가의 임상 시험 환경을 육성하기 위해 외국 투자를 유치하기 시작했습니다. 2019년에 총 ~US$62.67 million(ZAR 10억)이 다가오고 진행 중인 시험에 투자되었습니다. 2016-2021년 동안 남아프리카 공화국에서 운영되는 혁신적인 다국적 제약 회사는 국가의 충족되지 않은 의료적 요구를 해결하는 데 중점을 둔 임상 연구 활동을 지원하기 위해 ~US$0.18 billion(ZAR 29.5 billion)을 지출했습니다.
남아프리카 공화국은 아프리카 대륙에서 가장 경제적으로 발전한 국가이며 임상 시험에 대한 더 나은 규제 기준을 수립했습니다. 임상 연구 운영 비용이 낮고 소송 위험이 적기 때문에 남아프리카 공화국은 임상 연구 운영을 아웃소싱하는 외국 기업에 매력적인 옵션입니다. 게다가 모집률이 높고 국가의 규제 환경이 개선되어 임상 시험 수가 증가하고 있습니다. 남아프리카 공화국은 임상 연구를 수행하기 위해 혁신적인 제약 회사로부터 상당한 후원을 받고 있으며, 둔화될 조짐은 보이지 않습니다. 따라서 임상 연구 산업의 발전은 이 나라의 약동학 서비스 시장 성장을 뒷받침합니다.
중동 및 아프리카 약동학 서비스 시장 수익 및 2031년까지의 예측(백만 달러)
중동 및 아프리카 약동학 서비스 시장 세분화
중동 및 아프리카 약동학 서비스 시장은 약물 유형, 서비스 유형, 치료적 적용, 최종 사용자 및 국가로 분류됩니다.
약물 유형을 기준으로 중동 및 아프리카 약동학 서비스 시장은 소분자, 대분자 및 백신으로 세분화됩니다. 소분자 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
서비스 유형 측면에서 중동 및 아프리카 약동학 서비스 시장은 임상 전 ADME 및 인체 연구, PK/PD 분석 및 보고, 투여 시뮬레이션, 위험 분석 등으로 분류됩니다. 임상 전 ADME 및 인체 연구 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
치료적 적용 기준으로 중동 및 아프리카 약동학 서비스 시장은 종양학, 감염성 질환, 신경계 질환, 자가면역 질환, 부인과 질환, 심혈관 질환, 호흡기 질환 등으로 세분화됩니다. 종양학 세그먼트는 2023년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용자 기준으로 중동 및 아프리카 약동학 서비스 시장은 제약 및 생명 공학 회사, 계약 연구 기관 등으로 세분화됩니다. 계약 연구 기관 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 중동 및 아프리카 약동학 서비스 시장은 남아프리카, 사우디 아라비아, UAE, 그리고 중동 및 아프리카의 나머지 지역으로 세분화됩니다. 남아프리카는 2023년에 중동 및 아프리카 약동학 서비스 시장 점유율을 지배했습니다.
Charles River Laboratories International Inc; Eurofins Scientific SE; Certara Inc.; Parexel International Corp; Thermo Fisher Scientific Inc.; Allucent; PACIFIC BIOLABS; 그리고 SGS SA는 중동 및 아프리카 약동학 서비스 시장에서 운영되는 선도적인 회사들 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmacokinetics Services Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Expanding Range of Application of Pharmacokinetic Studies
4.1.3 Outsourcing of Pharmacokinetics Services to CROs
4.2 Market Restraints
4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
4.3 Market Opportunities
4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
4.4 Future Trend
4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
4.5 Impact of Drivers and Restraints:
5. Pharmacokinetics Services Market - Middle East & Africa Analysis
5.1 Middle East & Africa Pharmacokinetics Services Market Overview
5.2 Middle East & Africa Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Pharmacokinetics Services Market Analysis - by Drug Type
6.1 Overview
6.2 Small Molecule
6.2.1 Overview
6.2.2 Small Molecule: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Large Molecule
6.3.1 Overview
6.3.2 Large Molecule: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7. Middle East & Africa Pharmacokinetics Services Market Analysis - by Service Type
7.1 Overview
7.2 Pre-Clinical ADME and Human Studies
7.2.1 Overview
7.2.2 Pre-Clinical ADME and Human Studies: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 PK/PD Analysis and Reporting
7.3.1 Overview
7.3.2 PK/PD Analysis and Reporting: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Dosing Simulations
7.4.1 Overview
7.4.2 Dosing Simulations: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Risk Analysis
7.5.1 Overview
7.5.2 Risk Analysis: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Pharmacokinetics Services Market Analysis - by Therapeutic Application
8.1 Oncology
8.1.1 Overview
8.1.2 Oncology: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Infectious Diseases
8.2.1 Overview
8.2.2 Infectious Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Neurological Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Autoimmune Diseases
8.4.1 Overview
8.4.2 Autoimmune Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Gynecological Disorders
8.5.1 Overview
8.5.2 Gynecological Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Respiratory Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Pharmacokinetics Services Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
9.2.1 Overview
9.2.2 Contract Research Organization: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Pharmacokinetics Services Market - Country Analysis
10.1 Middle East and Africa
10.1.1 Middle East & Africa Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
10.1.1.1 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.1.4 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.1.5 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.1.6 Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market Breakdown, by End User
10.1.1.2 South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 South Africa: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.2.4 South Africa: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.2.5 South Africa: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.2.6 South Africa: Middle East & Africa Pharmacokinetics Services Market Breakdown, by End User
10.1.1.3 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.3.4 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.3.5 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.3.6 United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market Breakdown, by End User
10.1.1.4 Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.4.4 Rest of Middle East & Africa Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.4.5 Rest of Middle East & Africa Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.4.6 Rest of Middle East & Africa Pharmacokinetics Services Market Breakdown, by End User
11. Company Profile
11.1 Charles River Laboratories International Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eurofins Scientific SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Certara Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.4 Parexel International Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Thermo Fisher Scientific Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Allucent
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PACIFIC BIOLABS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SGS SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms for Pharmacokinetic Services Market
?
List of Tables
Table 1. Middle East & Africa Pharmacokinetics Services Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Drug Type
Table 3. Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Service Type
Table 4. Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Therapeutic Application
Table 5. Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by End User
Table 6. South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Drug Type
Table 7. South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Service Type
Table 8. South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Therapeutic Application
Table 9. South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by End User
Table 10. United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Drug Type
Table 11. United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Service Type
Table 12. United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Therapeutic Application
Table 13. United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by End User
Table 14. Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Drug Type
Table 15. Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Service Type
Table 16. Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by Therapeutic Application
Table 17. Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million) - by End User
Table 18. Glossary of Terms
?
List of Figures
Figure 1. Middle East & Africa Pharmacokinetics Services Market Segmentation, by Country
Figure 2. Middle East & Africa Pharmacokinetics Services Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
Figure 5. Middle East & Africa Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 6. Small Molecule: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Large Molecule: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Vaccines: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Middle East & Africa Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 10. Pre-Clinical ADME and Human Studies: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. PK/PD Analysis and Reporting: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Dosing Simulations: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Risk Analysis: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Middle East & Africa Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 16. Oncology: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Infectious Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Neurological Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Autoimmune Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gynecological Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Cardiovascular Diseases: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Respiratory Disorders: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Middle East & Africa Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 25. Pharmaceutical and Biotechnology Companies: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Contract Research Organization: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Middle East & Africa Pharmacokinetics Services Market by Key Countries - Revenue 2023 (US$ Million)
Figure 29. Middle East & Africa Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. Saudi Arabia: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million)
Figure 31. South Africa: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million)
Figure 32. United Arab Emirates: Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million)
Figure 33. Rest of Middle East & Africa Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)2031 (US$ Million)
- Allucent
- Certara Inc.
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- PACIFIC BIOLABS
- Parexel International Corp
- SGS SA
- Thermo Fisher Scientific Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa pharmacokinetics services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa pharmacokinetics services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Middle East & Africa pharmacokinetics services market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.